The effect of dipyridamole on adenosine uptake by platelets ex vivo

A Summers et al. Thromb Res. 1977 Nov.

. 1977 Nov;11(5):611-8.

doi: 10.1016/0049-3848(77)90019-6.

No abstract available

Similar articles

Effect of dipyridamole and its monoglucuronide derivative on adenosine uptake by human platelets and ADP-induced platelet aggregation.
Subbarao K, Rucinski B, Niewiarowski S. Subbarao K, et al. Biochem Pharmacol. 1977 May 1;26(9):906-7. doi: 10.1016/0006-2952(77)90413-0. Biochem Pharmacol. 1977. PMID: 861060 No abstract available.
Binding of dipyridamole to human platelets and to alpha1 acid glycoprotein and its significance for the inhibition of adenosine uptake.
Subbarao K, Rucinski B, Rausch MA, Schmid K, Niewiarowski S. Subbarao K, et al. J Clin Invest. 1977 Oct;60(4):936-43. doi: 10.1172/JCI108848. J Clin Invest. 1977. PMID: 893681 Free PMC article.
Pharmacokinetics of oral dipyridamole (Persantine) and its effect on platelet adenosine uptake in man.
Dresse A, Chevolet C, Delapierre D, Masset H, Weisenberger H, Bozler G, Heinzel G. Dresse A, et al. Eur J Clin Pharmacol. 1982;23(3):229-34. doi: 10.1007/BF00547559. Eur J Clin Pharmacol. 1982. PMID: 6756935 Clinical Trial.
[Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
Jobin F. Jobin F. Union Med Can. 1976 Aug;105(8):1159-73. Union Med Can. 1976. PMID: 10662 Review. French. No abstract available.
Platelets and thrombogenesis--current concepts.
Schnetzer GW 3rd. Schnetzer GW 3rd. Am Heart J. 1972 Apr;83(4):552-64. doi: 10.1016/0002-8703(72)90048-8. Am Heart J. 1972. PMID: 4339454 Review. No abstract available.

Effects of dipyridamole in vivo on ATP and cAMP content in platelets and arterial walls and on atherosclerotic plaque formation.
Dembinska-Kiec A, Rücker W, Schönhöfer PS. Dembinska-Kiec A, et al. Naunyn Schmiedebergs Arch Pharmacol. 1979 Oct;309(1):59-64. doi: 10.1007/BF00498756. Naunyn Schmiedebergs Arch Pharmacol. 1979. PMID: 230417